278 related articles for article (PubMed ID: 16680126)
21. Little biotech on the prairie.
Wolfson W
Chem Biol; 2007 Sep; 14(9):969-71. PubMed ID: 17884626
[No Abstract] [Full Text] [Related]
22. Developments and improvements in the manufacturing of human therapeutics with mammalian cell cultures.
Hesse F; Wagner R
Trends Biotechnol; 2000 Apr; 18(4):173-80. PubMed ID: 10740264
[TBL] [Abstract][Full Text] [Related]
23. 2011 in reflection.
Mullard A
Nat Rev Drug Discov; 2012 Jan; 11(1):6-8. PubMed ID: 22212664
[No Abstract] [Full Text] [Related]
24. Deal watch: Trends in platform technology deal-making.
Walker J; Jacob J
Nat Rev Drug Discov; 2009 Dec; 8(12):923. PubMed ID: 19949395
[No Abstract] [Full Text] [Related]
25. How information technologies have improved both productivity and quality of health care.
Jiang ST
J Med Eng Technol; 2005; 29(1):38-41. PubMed ID: 15764381
[No Abstract] [Full Text] [Related]
26. Editorial: between molecular and macroscopic protein engineering.
Jungbauer A
Biotechnol J; 2008 Feb; 3(2):143. PubMed ID: 18283675
[No Abstract] [Full Text] [Related]
27. Chinese biotech hamstrung by production issues.
Jia H
Nat Biotechnol; 2007 Feb; 25(2):147-8. PubMed ID: 17287733
[No Abstract] [Full Text] [Related]
28. Mixing in process vessels used in biopharmaceutical manufacturing.
Ram K; Vickroy TB; Lamb KA; Slater NK; Dennis JS; Duffy LE
Biotechnol Prog; 2000; 16(2):244-7. PubMed ID: 10753450
[TBL] [Abstract][Full Text] [Related]
29. Cell biology: ion channels and stem cells.
Moore P
Nature; 2005 Dec; 438(7068):699-704. PubMed ID: 16319900
[No Abstract] [Full Text] [Related]
30. Downstream processing of value-added proteins in biotechnology: An Indian scenario.
Babu AK; Vijayalakshmi MA
Biotechnol J; 2009 Aug; 4(8):1132-9. PubMed ID: 19360713
[No Abstract] [Full Text] [Related]
31. Russia through the prism of the world biopharmaceutical market.
Bairamashvili DI; Rabinovich ML
Biotechnol J; 2007 Jul; 2(7):801-17. PubMed ID: 17615600
[TBL] [Abstract][Full Text] [Related]
32. Continuous bioprocessing: the real thing this time? 10(th) Annual bioProcessUK Conference, December 3-4, 2013, London, UK.
Farid SS; Thompson B; Davidson A
MAbs; 2014; 6(6):1357-61. PubMed ID: 25484060
[TBL] [Abstract][Full Text] [Related]
33. Profiles of four top biotech companies in India.
Suresh N; Rao ChS
Biotechnol J; 2009 Mar; 4(3):295-300. PubMed ID: 19296435
[No Abstract] [Full Text] [Related]
34. Changes in the business of culture.
Pissarra Pde N
Nat Biotechnol; 2004 Nov; 22(11):1355-6. PubMed ID: 15529153
[No Abstract] [Full Text] [Related]
35. A rollercoaster ride.
Jacobs T
Nat Biotechnol; 2006 Mar; 24(3):284. PubMed ID: 16525390
[No Abstract] [Full Text] [Related]
36. SNP market view: opportunities, technologies, and products.
Wypgant M
Biotechniques; 2002 Jun; Suppl():78-80, 82, 84 passim. PubMed ID: 12083402
[No Abstract] [Full Text] [Related]
37. Uncorking the biomanufacturing bottleneck.
Dove A
Nat Biotechnol; 2002 Aug; 20(8):777-9. PubMed ID: 12148000
[No Abstract] [Full Text] [Related]
38. [Will genes become an engine to the industry?].
Nylund S; Sibakov M
Duodecim; 2000; 116(16):1763-8. PubMed ID: 12001455
[No Abstract] [Full Text] [Related]
39. High-throughput process development for biopharmaceutical drug substances.
Bhambure R; Kumar K; Rathore AS
Trends Biotechnol; 2011 Mar; 29(3):127-35. PubMed ID: 21255855
[TBL] [Abstract][Full Text] [Related]
40. Industrialization of mAb production technology: the bioprocessing industry at a crossroads.
Kelley B
MAbs; 2009; 1(5):443-52. PubMed ID: 20065641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
